NewMed Medical and Founder Dr. Yu Qifeng Honored in Hurun's 2024 China Healthcare Emerging Forces and Young Entrepreneurs Lists Amid Latest HKEX IPO Filing

Dec 11, 2024 09:31 CST Updated 09:31

NewMed

Artificial Heart Valve System Developer

On December 5, the Hurun Research Institute, in collaboration with Baoding International Medical Center, jointly released the "2024 Hurun China Emerging Healthcare Companies" and "2024 Hurun China Young Healthcare Entrepreneurs" lists. The aim is to identify Chinese healthcare companies established within the past 10 years that demonstrate growth potential, as well as young entrepreneurs aged 45 and under who have made outstanding contributions to the industry’s development, fostering discussions on the advancement and innovation of the healthcare sector. This marks the first time that the Hurun Research Institute has focused on emerging healthcare companies and young entrepreneurs in releasing these lists.

Shanghai NewMed Medical Co., Ltd. ("NewMed") has been selected for the "2024 Hurun China New Medical Powerhouse Enterprises" list, and Dr. Yu Qifeng, founder, chairman, and CEO of NewMed, has been named to the "2024 Hurun China Young Healthcare Entrepreneurs" list.

The "2024 Hurun China Emerging Medical Companies" list focuses on emerging Chinese medical companies established in 2014 or later, covering three major fields: pharmaceuticals, medical devices, and medical services. This time, NewMed has been selected for the list of emerging medical companies due to its outstanding innovation capabilities in medical devices. This not only represents high recognition of NewMed's comprehensive strength but also provides strong support for the company’s continued focus and practice in the field of heart disease treatment.

Rupert Hoogewerf, Chairman and Chief Research Officer of Hurun GroupSaid: "The medical industry is the next most promising development track globally. Among the future unicorns selected by Hurun in recent years, the highest number comes from the medical industry, with more than half being Chinese companies. In the Hurun China 500, healthcare is the largest industry; in the Hurun Global 500, healthcare ranks as the third-largest industry after financial services and energy."

Emerging Healthcare Companies Subdivided into Three Tracks: Medical Services, Pharmaceutical, and Medical Devices. Among them, medical devices account for 19%, mainly including therapeutic devices and diagnostic equipment.

Dr. Yu Qifeng

Founder, Chairman and CEO of NewMed

We are delighted to see NewMed recognized by the Hurun ranking, which serves as a continuous source of motivation and affirmation for our efforts in advancing value creation within the field of heart disease. Innovation remains the core driving force behind corporate growth and is also key to new productive forces, propelling profound transformation and upgrading within the healthcare industry. On the medical device track, full of opportunities and challenges, NewMed upholds its mission of "Innovating to Benefit Life," consistently focusing on the research and development, as well as the industrialization, of advanced interventional artificial heart valve systems at an international level, providing comprehensive and innovative solutions for valve intervention treatments in China. Behind every achievement of the company lies the result of countless trials and optimizations by the team, representing a bold leap forward in pushing the boundaries of technology.

Being selected for the list this time is not only a recognition of NewMed's strength but also a new starting point. The company will take this as an opportunity to further deepen technological innovation, accelerate product iteration and upgrades, and provide patients with safer and more effective cardiac treatment solutions.

Attachment

Full List